Stamp Out Lyme Disease Act proposes a semipostal stamp to fund Lyme disease research.
The Stamp Out Lyme Disease Act proposes the issuance of a semipostal stamp to fund Lyme disease and related tick-borne illness research within the National Institute of Allergy and Infectious Diseases. The stamp will be available for at least six years. Proceeds from the stamp sales will be transferred to the National Institute of Allergy and Infectious Diseases, exempt from consideration in federal funding decisions. The act aims to address the high annual cost of Lyme disease to the U.S. healthcare system and the challenges in diagnosing and treating the disease.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.